General Information of the Compound
Compound ID
CP0472922
Compound Name
4-[2-(1,2,3,4-tetrahydropyrido[3,4-b]indol-9-ylmethyl)benzimidazol-1-yl]butan-1-ol
    Show/Hide
Structure
Formula
C23H26N4O
Molecular Weight
374.488
Canonical SMILES
OCCCCn1c(Cn2c3CNCCc3c3ccccc23)nc2ccccc12
    Show/Hide
InChI
InChI=1S/C23H26N4O/c28-14-6-5-13-26-21-10-4-2-8-19(21)25-23(26)16-27-20-9-3-1-7-17(20)18-11-12-24-15-22(18)27/h1-4,7-10,24,28H,5-6,11-16H2
    Show/Hide
InChIKey
DJVHDNQFYKNAOE-UHFFFAOYSA-N
Physicochemical Property
logP
3.4575
Rotatable Bonds
6
Heavy Atom Count
28
Polar Areas
55.01
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 145953327
ChEMBL ID
CHEMBL4166061
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00459, Fusion glycoprotein F0
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000668 HEp-2 Homo sapiens (Human)  1
1
EC50 = 5000 nM
   TI
   LI
   LO
   TS